Scholars Central

Mini reviewPublished 30 Apr 2024

Evolution in Medicine: Exploring Second Generation Pharmaceuticals

Authors: Carlo Gotlib

Department of Pharmacology, University of Berlin, Germany

Clinical Pharmacology & Biopharmaceutics

Volume 13 · Issue 4 · Pages 01–02

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Second generation pharmaceuticals herald a new era of innovation and precision in drug development, offering enhanced therapeutic efficacy and safety compared to their predecessors. This abstract delves into the transformative potential of second generation medications, which are characterized by targeted approaches, biotechnological advancements, and personalized treatment strategies. By leveraging cutting-edge science and interdisciplinary collaboration, these medications hold the promise of revolutionizing disease management and improving patient outcomes. As we navigate the evolving landscape of pharmaceuticals, embracing the potential of second generation therapies offers new hope for addressing unmet medical needs and shaping the future of medicine.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Carlo Gotlib”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels